Literature DB >> 15655718

Gastrointestinal hormones and regulation of food intake.

W S Dhillo1, S R Bloom.   

Abstract

Obesity has been described as the greatest current threat to human health. In order to design drugs to target obesity, it is essential to understand its physiology and pathophysiology. Several peptides synthesised in the gastrointestinal tract which affect food intake have been identified including ghrelin, cholecystokinin (CCK), glucagon-like peptide-1 (7-36) amide (GLP-1), oxyntomodulin, peptide YY (PYY) and pancreatic polypeptide (PP). These peptides represent potential targets for the design of anti-obesity drugs. In this article we review recent advances in our understanding of food intake by these gastrointestinal hormones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655718     DOI: 10.1055/s-2004-826174

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  12 in total

Review 1.  Obesity and its therapy: from genes to community action.

Authors:  Joseph A Skelton; Laure DeMattia; Lawrence Miller; Michael Olivier
Journal:  Pediatr Clin North Am       Date:  2006-08       Impact factor: 3.278

Review 2.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 3.  The physiology underlying Roux-en-Y gastric bypass: a status report.

Authors:  Thomas A Lutz; Marco Bueter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

4.  Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner.

Authors:  C Folgueira; E Sanchez-Rebordelo; S Barja-Fernandez; R Leis; S Tovar; F F Casanueva; C Dieguez; R Nogueiras; L M Seoane
Journal:  Eur J Nutr       Date:  2015-03-06       Impact factor: 5.614

5.  Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study.

Authors:  Giovanni Albani; Maria Letizia Petroni; Alessandro Mauro; Antonio Liuzzi; Giovanni Lezzi; Barbara Verti; Paolo Marzullo; Laila Cattani
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

6.  Ghrelin action in the brain controls adipocyte metabolism.

Authors:  Claudia Theander-Carrillo; Petra Wiedmer; Philippe Cettour-Rose; Ruben Nogueiras; Diego Perez-Tilve; Paul Pfluger; Tamara R Castaneda; Patrick Muzzin; Annette Schürmann; Ildiko Szanto; Matthias H Tschöp; Françoise Rohner-Jeanrenaud
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

7.  Imaging mass spectrometry of neuropeptides in decapod crustacean neuronal tissues.

Authors:  Stephanie S DeKeyser; Kimberly K Kutz-Naber; Joshua J Schmidt; Gregory A Barrett-Wilt; Lingjun Li
Journal:  J Proteome Res       Date:  2007-03-24       Impact factor: 4.466

Review 8.  Pathophysiology of obesity: why surgery remains the most effective treatment.

Authors:  Talat Waseem; Kris M Mogensen; David B Lautz; Malcolm K Robinson
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

9.  Photoperiodic regulation of satiety mediating neuropeptides in the brainstem of the seasonal Siberian hamster (Phodopus sungorus).

Authors:  Michael Helwig; Zoë A Archer; Gerhard Heldmaier; Alexander Tups; Julian G Mercer; Martin Klingenspor
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2009-04-05       Impact factor: 1.836

10.  Limiting glucocorticoid secretion increases the anorexigenic property of Exendin-4.

Authors:  Shin J Lee; Katharina Diener; Sharon Kaufman; Jean-Philippe Krieger; Klaus G Pettersen; Nino Jejelava; Myrtha Arnold; Alan G Watts; Wolfgang Langhans
Journal:  Mol Metab       Date:  2016-05-04       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.